Group purchasing organization Novation put the spotlight on St. Jude Medical and its top 9 game-changing technologies.

Group purchasing organization Novation put the spotlight on St. Jude Medical (NYSE:STJ) in the latest issue of the GPO's EuroPCR report, CVWatch.

The dispatch, "intended to promote innovation, while providing clinical and economic highlights of these new technologies that have a high probability of impacting the member hospitals we serve," highlighted St. Jude and a slate of the company's cardiovascular devices, including the Nanostim wireless pacemaker and Amplatzer left atrial occluder.